Drawing for INVITA HEALTHCARE SOLUTIONS

USPTO serial 88600149

INVITA HEALTHCARE SOLUTIONS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SAKAI, ADA HAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INVITA HEALTHCARE SOLUTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ned T. Himmelrich

Ned T. Himmelrich GORDON FEINBLATT LLC233 E REDWOOD STBALTIMORE, MD 21202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Recorded software and downloadable software for managing patient intake, scheduling medical services, controlling and managing patient medical information, processing and displaying medical treatment information, exchanging and managing medical treatment information, managing health care workflows, managing patient accounts, medical billing, medical vendor and manufacturer billing, tracking patient outcomes, tracking healthcare provider services, and analyzing health care business operations; recorded software and downloadable software for supply chain management, vendor management, manufacturer management, storage management, inventory management, usage tracking, waste tracking, specification tracking, regulatory tracking, warranty record management, warranty claim management, and recall claim management of biologics, vaccines, pharmaceuticals, implants, tissues, medical devices, medical equipment, and medical supplies; recorded software and downloadable software for managing the collection and delivery of biologics, namely, recruiting and conversion of blood donors, engaging blood donors, managing blood donation centers, providing user portal access, managing mobile blood drives, managing human resources, managing health care provider orders, planning for blood product demand, maintaining quality control of blood products and equipment, scheduling equipment calibration, providing voice over internet protocol communications, providing cloud calling communications, and providing text messagingACTIVE—
042Software as a service (SAAS) services featuring software for managing patient intake, scheduling medical services, controlling and managing patient medical information, processing and displaying medical treatment information, exchanging and managing medical treatment information, managing health care workflows, managing patient accounts, medical billing, medical vendor and manufacturer billing, tracking patient outcomes, tracking healthcare provider services, and analyzing health care business operations; SAAS services featuring software for supply chain management, vendor management, manufacturer management, storage management, inventory management, usage tracking, waste tracking, specification tracking, regulatory tracking, warranty record management, warranty claim management, and recall claim management of biologics, vaccines, pharmaceuticals, implants, tissues, medical devices, medical equipment, and medical supplies; SAAS services featuring software for managing the collection and delivery of biologics, namely, recruiting and conversion of blood donors, engaging blood donors, managing blood donation centers, providing user portal access, managing mobile blood drives, managing human resources, managing health care provider orders, planning for blood product demand, maintaining quality control of blood products and equipment, scheduling equipment calibration, providing voice over internet protocol communications, providing cloud calling communications, and providing text messagingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 13, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 12, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 9, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 9, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 9, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 9, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 9, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 10, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 25, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 9, 2019ALIEASSIGNED TO LIE—
Dec 6, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 6, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Dec 6, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 6, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 6, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 4, 2019DOCKASSIGNED TO EXAMINER—
Sep 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 3, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance